up to 80,000 hospitalizations and up to 300 deaths per year in the U.S. Most people are infected by age 2.
Active immunization refers to the protection from vaccines, but no RSV vaccine for infants has been approved. In a study of nearly 1,500 infants, the shot lowered the risk of developing respiratory disease from RSV that required a doctor's visit by nearly 75% for at least five months. “The studies as presented showed clear evidence of efficacy and reassuring evidence of safety across all the subgroups presented, and I think that this could be a real game changer,” said Dr. George Siberry, a member of the FDA panel and a medical officer at the U.S. Agency for International Development.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisors recommend AstraZeneca antibody to protect babies from RSVIf the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV.
Source: CNBC - 🏆 12. / 72 Read more »
FDA OKs Letermovir to Prevent CMV in Kidney TransplantsLetermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication.
Source: Medscape - 🏆 386. / 55 Read more »
FDA Finalizes Limit on How Much Arsenic Can Be in Apple JuiceFederal regulators have finalized new guidance on how much inorganic arsenic can be present in apple juice, in an effort to limit the exposure of infants and young children to this environmental contaminant.
Source: MedicineNet - 🏆 575. / 51 Read more »
FDA clears Lynparza for prostate cancer treatmentThe Food and Drug Administration cleared a new cancer-fighting drug called Lynparza for prostate cancer treatment.
Source: wsyx6 - 🏆 444. / 53 Read more »
FDA warns against self-diagnosis, bogus treatments for this common skin conditionThe Food and Drug Administration is warning against self-diagnosis and self-treatment for a common skin condition - a viral infection often called 'water warts.'
Source: ABC7 - 🏆 67. / 68 Read more »
Eisai-Biogen Alzheimer's drug data confirms benefits, FDA staff saysU.S. Food and Drug Administration staff on Wednesday said data from a late-stage trial of Eisai and Biogen's Alzheimer's disease drug suggests it offered a meaningful benefit to patients and safety concerns likely would not hamper its chances of a traditional approval.
Source: Reuters - 🏆 2. / 97 Read more »